Logo image of PHH

PARK HA BIOLOGICAL TECHNOLOG (PHH) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:PHH - KYG6925R1020 - Common Stock

0.385 USD
0 (-0.08%)
Last: 10/27/2025, 8:00:00 PM
0.4112 USD
+0.03 (+6.81%)
After Hours: 10/27/2025, 8:00:00 PM
Fundamental Rating

3

Overall PHH gets a fundamental rating of 3 out of 10. We evaluated PHH against 121 industry peers in the Specialty Retail industry. While PHH has a great health rating, there are worries on its profitability. PHH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year PHH has reported negative net income.
  • In the past year PHH had a positive cash flow from operations.
PHH Yearly Net Income VS EBIT VS OCF VS FCFPHH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 500K 1M

1.2 Ratios

  • With a Return On Assets value of -331.89%, PHH is not doing good in the industry: 97.54% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -455.43%, PHH is doing worse than 79.51% of the companies in the same industry.
Industry RankSector Rank
ROA -331.89%
ROE -455.43%
ROIC N/A
ROA(3y)20.25%
ROA(5y)N/A
ROE(3y)81.07%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PHH Yearly ROA, ROE, ROICPHH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 20 40 60 80 100

1.3 Margins

  • PHH's Gross Margin of 92.99% is amongst the best of the industry. PHH outperforms 97.54% of its industry peers.
  • The Profit Margin and Operating Margin are not available for PHH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 92.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHH Yearly Profit, Operating, Gross MarginsPHH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 20 40 60 80

More info and screens

9

2. Health

2.1 Basic Checks

  • PHH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for PHH has been reduced compared to 1 year ago.
  • There is no outstanding debt for PHH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
PHH Yearly Shares OutstandingPHH Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M 25M
PHH Yearly Total Debt VS Total AssetsPHH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 1M 2M 3M

2.2 Solvency

  • PHH has an Altman-Z score of 21.30. This indicates that PHH is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 21.30, PHH belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • PHH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 21.3
ROIC/WACCN/A
WACC8.04%
PHH Yearly LT Debt VS Equity VS FCFPHH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 500K 1M 1.5M

2.3 Liquidity

  • A Current Ratio of 3.68 indicates that PHH has no problem at all paying its short term obligations.
  • PHH has a Current ratio of 3.68. This is amongst the best in the industry. PHH outperforms 92.62% of its industry peers.
  • PHH has a Quick Ratio of 3.63. This indicates that PHH is financially healthy and has no problem in meeting its short term obligations.
  • PHH has a Quick ratio of 3.63. This is amongst the best in the industry. PHH outperforms 96.72% of its industry peers.
Industry RankSector Rank
Current Ratio 3.68
Quick Ratio 3.63
PHH Yearly Current Assets VS Current LiabilitesPHH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M 2.5M

More info and screens

1

3. Growth

3.1 Past

  • PHH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2189.24%.
  • PHH shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.33%.
EPS 1Y (TTM)-2189.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38931.58%
Revenue 1Y (TTM)9.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%45.29%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PHH Yearly Revenue VS EstimatesPHH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • PHH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PHH Price Earnings VS Forward Price EarningsPHH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHH is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 85.27
EV/EBITDA N/A
PHH Per share dataPHH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.02 -0.04 -0.06 -0.08

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for PHH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PARK HA BIOLOGICAL TECHNOLOG / PHH FAQ

Can you provide the ChartMill fundamental rating for PARK HA BIOLOGICAL TECHNOLOG?

ChartMill assigns a fundamental rating of 3 / 10 to PHH.


What is the valuation status of PARK HA BIOLOGICAL TECHNOLOG (PHH) stock?

ChartMill assigns a valuation rating of 1 / 10 to PARK HA BIOLOGICAL TECHNOLOG (PHH). This can be considered as Overvalued.


What is the profitability of PHH stock?

PARK HA BIOLOGICAL TECHNOLOG (PHH) has a profitability rating of 1 / 10.